Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Familial periodic paralysis
ADR ID BADD_A07216
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.10      Neurological disorders congenital
03.10.01      Neurological disorders congenital NEC
03.10.01.008      Familial periodic paralysis
17      Nervous system disorders
17.19      Congenital and peripartum neurological conditions
17.19.02      Congenital and hereditary neurological disorders NEC
17.19.02.007      Familial periodic paralysis
Description A heterogenous group of inherited disorders characterized by recurring attacks of rapidly progressive flaccid paralysis or myotonia. These conditions have in common a mutation of the gene encoding the alpha subunit of the sodium channel in skeletal muscle. They are frequently associated with fluctuations in serum potassium levels. Periodic paralysis may also occur as a non-familial process secondary to THYROTOXICOSIS and other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1481) [MeSH]
MedDRA Code 10016208
MeSH ID D010245; D010245; D020514; D010245; D020513
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Familial periodic paralysis | Hypokalaemic periodic paralysis | Hypokalemic periodic paralysis | Hyperkalaemic periodic paralysis | Hyperkalemic periodic paralysis | Paralyses, Familial Periodic | Familial Periodic Paralyses | Periodic Paralyses, Familial | Familial Periodic Paralysis | Periodic Paralysis, Familial | Paralysis, Familial Periodic | Normokalemic Periodic Paralysis | Normokalemic Periodic Paralyses | Paralyses, Normokalemic Periodic | Paralysis, Normokalemic Periodic | Periodic Paralyses, Normokalemic | Periodic Paralysis, Normokalemic
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00178Atenolol0.000074%
BADD_D00412Cephalexin0.000116%
BADD_D00623Dexamethasone0.001030%
BADD_D00979Furosemide0.000063%
BADD_D01285Levothyroxine0.000023%
BADD_D02066Spironolactone0.000173%
BADD_D02247Topiramate0.000837%
BADD_D02433Salbutamol0.000026%
The 1th Page    1    Total 1 Pages